Evidence map›Paper›PMID 26543599›Full record

ReviewJournal of thoracic disease2015

Current challenges in interventional mitral valve treatment.

Maurizio Taramasso, Alessandro Candreva, Alberto Pozzoli, Andrea Guidotti, Oliver Gaemperli, Fabian Nietlispach, Jens Barthelmes, Maximilian Y Emmert, Alberto Weber, Stefano Benussi and 2 more

Abstract readReview
In one paragraph

Review in Journal of thoracic disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Dynamic, patient-specific mitral valve modelling for planning transcatheter repairs.International journal of computer assisted radiology and surgery · 2019
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maurizio Taramasso1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Alessandro Candreva1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Alberto Pozzoli1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Andrea Guidotti1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Oliver Gaemperli1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Fabian Nietlispach1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Jens Barthelmes1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Maximilian Y Emmert1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Alberto Weber1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Stefano Benussi1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Ottavio Alfieri1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.
Francesco Maisano1 Klinik für Herz- und Gefässchirurgie, UniversitätsSpital Zürich, Zurich, Switzerland ; 2 San Raffaele University Hospital, Milan, Italy ; 3 Klinik für Kardiologie, UniversitätsSpital Zürich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter mitral valve therapies have emerged as an alternative option in high surgical risk or inoperable patients with severe and symptomatic mitral regurgitation (MR). As multiple technologies and different approaches will become available in the field of mitral valve interventions, different challenges are emerging, both patient- (clinical challenges) and procedure-related (technical challenges). This review will briefly explore the current open challenges in the evolving fields of interventional mitral valve treatment.

Indexed as

high riskimagingMitral valvetranscatheter mitral valve therapies

Identifiers

PMID26543599
PMCPMC4598533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.